Skip to main content
Clinical Trials/NCT05747443
NCT05747443
Active, not recruiting
Not Applicable

Multilevel Interventions to Increase Adherence to Lung Cancer Screening

Kaiser Permanente1 site in 1 country1,606 target enrollmentDecember 12, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Kaiser Permanente
Enrollment
1606
Locations
1
Primary Endpoint
Rate of repeat annual lung cancer screening
Status
Active, not recruiting
Last Updated
4 months ago

Overview

Brief Summary

Screening for lung cancer has the potential for a profound public health benefit. Repeat annual screening is necessary for early detection of lung cancer. The investigators will test two interventions which include patient education and reminders to improve adherence to lung cancer screening.

Detailed Description

Screening for lung cancer has the potential for a profound public health benefit. Successful population-based screening requires continuous monitoring to adherence repeat screening in high risk adults to achieve similar results. Repeat annual screening is necessary for early detection of lung cancer. Baseline or first LDCT scans detect prevalent lung cancer, when subsequent screening detects new nodules. However, adherence to screening is low, ranging at 28-38% from centers nationally. The investigators developed two novel, patient-centered interventions to address patient education and offering reminders for on-time screening. To address these goals, the specific aims are to: 1) Compare effectiveness of two multilevel interventions relative to usual care in improving (a) rates of adherence to lung cancer screening, (b) patient-centered outcomes; and (c) clinic outcomes; and 2) Determine the patient-, clinician-, and system-level factors that influence changes in adherence to inform lung cancer screening programs.

Registry
clinicaltrials.gov
Start Date
December 12, 2022
End Date
June 30, 2026
Last Updated
4 months ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • KPWA members
  • Aged 50-78 years
  • Have a negative screening LDCT scan
  • Speak English or Spanish
  • Meet US Preventive Services Task Force guidelines

Exclusion Criteria

  • Patients who were previously diagnosed with lung cancer,
  • Patients who have a positive scan,
  • Patients who have an indicator for interpreter services, except for Spanish

Outcomes

Primary Outcomes

Rate of repeat annual lung cancer screening

Time Frame: 9-15 months after index LDCT

Electronic health records will be searched for screening low dose CT (LDCT).

Secondary Outcomes

  • Knowledge of lung cancer screening(8 weeks after index LDCT)
  • Attitudes and beliefs(8 weeks after index LDCT)

Study Sites (1)

Loading locations...

Similar Trials